Skip to Content

Λ15 (Oxybutynin Chloride Extended-Release 15 mg)

Pill with imprint Λ15 is White, Round and has been identified as Oxybutynin Chloride Extended-Release 15 mg. It is supplied by Advagen Pharma Limited.

Oxybutynin is used in the treatment of urinary frequency; urinary incontinence; dysuria and belongs to the drug class urinary antispasmodics. There is no proven risk in humans during pregnancy. Oxybutynin 15 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for Λ15

Oxybutynin Chloride Extended-Release

Imprint
Λ15
Strength
15 mg
Color
White
Shape
Round
Availability
Rx and/or OTC
Drug Class
Urinary antispasmodics
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Advagen Pharma Limited
Manufacturer
Rubicon Research Private Limited
National Drug Code (NDC)
72888-0033

Get help with Imprint Code FAQs.

Related Images for "Λ15"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.